What is neonatal abstinence syndrome and what are its public health implications?

• A. Neonatal withdrawal in newborns exposed to opioids in utero; implications include longer hospital stays, increased care needs, and need for maternal treatment.
• B. Neonatal overdose in newborns due to maternal cocaine use.
• C. A disease in adults due to opioid addiction.
• D. A genetic syndrome.

Answer: (A)

Neonatal abstinence syndrome is the withdrawal symptoms that newborns can experience after being exposed to addictive substances, most commonly opioids, while in the womb. When a pregnant person uses opioids, the fetus becomes physiologically dependent. After birth, the drug exposure stops, and the infant may go through withdrawal which can show up as irritability, tremors, feeding difficulties, sweating, sleep problems, and other symptoms. This condition is a medical issue for the baby and a public health concern because it reflects maternal opioid use and the need for coordinated care for both infant and mother.

Public health implications include longer hospital stays for the infant, because withdrawal requires careful monitoring and sometimes pharmacologic treatment, and greater needs for specialized neonatal care and supportive services. There is also a clear link to maternal health services: addressing the mother's opioid use disorder through treatment and support can reduce NAS risk and improve outcomes for both mother and baby. On a broader level, NAS signals the importance of access to addiction treatment, coordinated care, and social support systems to mitigate long-term health and economic burdens on families and the healthcare system.

The other options describe different scenarios that do not match NAS: neonatal overdose from cocaine use refers to a different and distinct condition; NAS is not an adult disease or a genetic syndrome.